a randomized, double-blind, placebo-controlled trial to assess safety and tolerability during treatment of type 2 diabetes with usual diabetes therapy and either cycloset? or placebo一个随机、双盲、安慰剂对照试验来评估期间的安全性和耐受性与常规糖尿病治疗2型糖尿病的治疗和cycloset 或安慰剂.pdfVIP

a randomized, double-blind, placebo-controlled trial to assess safety and tolerability during treatment of type 2 diabetes with usual diabetes therapy and either cycloset? or placebo一个随机、双盲、安慰剂对照试验来评估期间的安全性和耐受性与常规糖尿病治疗2型糖尿病的治疗和cycloset 或安慰剂.pdf

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
a randomized, double-blind, placebo-controlled trial to assess safety and tolerability during treatment of type 2 diabetes with usual diabetes therapy and either cycloset? or placebo一个随机、双盲、安慰剂对照试验来评估期间的安全性和耐受性与常规糖尿病治疗2型糖尿病的治疗和cycloset 或安慰剂

BMC Endocrine Disorders BioMed Central Study protocol Open Access A randomized, double-blind, placebo-controlled trial to assess safety and tolerability during treatment of type 2 diabetes with usual diabetes therapy and either Cycloset™ or placebo 1 2 3 1 Richard E Scranton* , J Michael Gaziano , Dean Rutty , Michael Ezrokhi and Anthony Cincotta1 1 2 Address: Veroscience LLC, Tiverton RI, Harvard Medical School, Boston, USA, Division of Aging, Brigham Womens Hospital, Harvard Medical School, Boston, USA and 3Everest Clinical Research Services Inc., Toronto, Canada Email: Richard E Scranton* - richard_scranton@; J Michael Gaziano - jmgaziano@; Dean Rutty - dean_rutty@; Michael Ezrokhi - michael_ezrokhi@; Anthony Cincotta - anthony_cincotta@ * Corresponding author Published: 25 June 2007 Received: 12 April 2007 Accepted: 25 June 2007 BMC Endocrine Disorders 2007, 7:3 doi:10.1186/1472-6823-7-3 This article is available from: /1472-6823/7/3 © 2007 Scranton et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Background: Cycloset™ is a quick-release formulation of bromocriptine mesylate, a dopamine agonist, which in animal models of insulin resi

您可能关注的文档

文档评论(0)

118zhuanqian + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档